Pro Medicus Limited (PMCUF) Q4 2025 Earnings Call Transcript

2025-08-14 02:59:01 ET

Pro Medicus Limited (PMCUF)

Q4 2025 Earnings Conference Call

August 13, 2025 09:00 PM ET

Company Participants

Clayton James Hatch - Chief Financial Officer

Sam Aaron Hupert - Co-Founder, CEO, MD & Executive Director

Conference Call Participants

Andrew Paine - CLSA Limited, Research Division

Annabel Li - Goldman Sachs Group, Inc., Research Division

Christine Trinh - Macquarie Research

David A. Low - JPMorgan Chase & Co, Research Division

Garry Sherriff - RBC Capital Markets, Research Division

John Hester - Bell Potter Securities Limited, Research Division

Josh Charles Kannourakis - Barrenjoey Markets Pty Limited, Research Division

Mathieu Chevrier - Citigroup Inc., Research Division

Presentation

Operator

Thank you for standing by, and welcome to the Pro Medicus Limited Full Year Results Briefing. [Operator Instructions] I would now like to hand the conference over to Dr. Sam Hupert, CEO. Please go ahead.

Sam Aaron Hupert

Thank you. Good morning, everybody, and thanks for joining us for our FY '25 full year results. As most of you know, we are leaders in enterprise imaging and radiology information systems. We work in 3 jurisdictions. Our group headquarter in Melbourne, Australia. Our R&D center and support center in Berlin. And our largest market, which is about 90% of our revenue from North America with our offices in San Diego.

We have 2 product lines in Australia. It's the Visage RIS, which does more of the practice management, back office billing scheduling and Visage 7, which is a clinical product. It's the radiologist desktop that they use to call up images, enhance them and make the diagnosis, and that's the product we sell globally and particularly in the U.S....

Read the full article on Seeking Alpha

For further details see: